BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6
55 results:

  • 1. Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study.
    Tian J; Wang H; Lu C; Liu L; Zhang X; Xie Y; Li R; Lv X; Fu D; Zhang L; Fang X; Wang X; Hu J; Liu X; Huang X; Zhao Q; Luo N; Tang H; Zhong Z; He Y; Li L
    Lung Cancer; 2023 Jul; 181():107255. PubMed ID: 37244039
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of the active compounds in the Yi-Fei-San-Jie formula using a comprehensive strategy based on cell extraction/UPLC-MS/MS, network pharmacology, and molecular biology techniques.
    Hu L; Luo J; Wen G; Sun L; Liu W; Hu H; Li J; Wang L; Su W; Lin L
    Phytomedicine; 2023 Jul; 115():154843. PubMed ID: 37149966
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Data-Driven Radiogenomic Approach for Deciphering Molecular Mechanisms Underlying Imaging Phenotypes in lung Adenocarcinoma: A Pilot Study.
    Fischer S; Spath N; Hamed M
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902378
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing.
    Machida H; Matsuo K; Tanaka M; Kitatani K; Takase A; Yokoyama K; Kajiwara H; Yasaka M; Ikeda M; Yoshida H; Hirasawa T; Mikami M
    Gynecol Oncol; 2023 Apr; 171():59-66. PubMed ID: 36804622
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Recruitment of LEF1 by Pontin chromatin modifier amplifies tgfbr2 transcription and activates TGFβ/SMAD signalling during gliomagenesis.
    Zhou X; Li X; Wang R; Hua D; Sun C; Yu L; Shi C; Luo W; Jiang Z; An W; Wang Q; Yu S
    Cell Death Dis; 2022 Sep; 13(9):818. PubMed ID: 36153326
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel circ_MACF1/miR-942-5p/tgfbr2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells.
    Fan D; Yang Y; Zhang W
    BMC Pulm Med; 2022 Jan; 22(1):27. PubMed ID: 34996416
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in lung Squamous Cell Carcinoma.
    Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
    DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Epithelial membrane protein 3 regulates lung cancer stem cells via the TGF‑β signaling pathway.
    Kahm YJ; Kim RK; Jung U; Kim IG
    Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34476496
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in lung Adenocarcinoma.
    Xu Z; Chen C
    Biomed Res Int; 2021; 2021():6663990. PubMed ID: 34036102
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting hyperactive tgfbr2 for treating MYOCD deficient lung cancer.
    Zhou Q; Chen W; Fan Z; Chen Z; Liang J; Zeng G; Liu L; Liu W; Yang T; Cao X; Yu B; Xu M; Chen YG; Chen L
    Theranostics; 2021; 11(13):6592-6606. PubMed ID: 33995678
    [No Abstract]    [Full Text] [Related]  

  • 11. Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in lung Adenocarcinoma.
    Chen L; Ren Z; Cai Y
    Biomed Res Int; 2021; 2021():4093426. PubMed ID: 33628780
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MicroRNA-320a: an important regulator in the fibrotic process in interstitial lung disease of systemic sclerosis.
    Li Y; Huang J; Hu C; Zhou J; Xu D; Hou Y; Wu C; Zhao J; Li M; Zeng X; Liu C; Wang Q; Zhao Y
    Arthritis Res Ther; 2021 Jan; 23(1):21. PubMed ID: 33430962
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
    Chen B; Zhang Y; Dai S; Zhou P; Luo W; Wang Z; Chen X; Cheng P; Zheng G; Ren J; Yang X; Li W
    Signal Transduct Target Ther; 2021 Jan; 6(1):6. PubMed ID: 33414372
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of tgfbr2 in non-small cell lung cancer.
    Lo Sardo F; Pulito C; Sacconi A; Korita E; Sudol M; Strano S; Blandino G
    Cancer Lett; 2021 Mar; 500():51-63. PubMed ID: 33296708
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Estimation of Hub Genes and Infiltrating Immune Cells in Non-Smoking Females with lung Adenocarcinoma by Integrated Bioinformatic Analysis.
    Li J; Wang B; Li X; Zhu Y
    Med Sci Monit; 2020 Jul; 26():e922680. PubMed ID: 32669531
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
    Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
    Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell lung cancer Using a Time-binned Deep Neural Network.
    Lee B; Chun SH; Hong JH; Woo IS; Kim S; Jeong JW; Kim JJ; Lee HW; Na SJ; Beck KS; Gil B; Park S; An HJ; Ko YH
    Sci Rep; 2020 Feb; 10(1):1952. PubMed ID: 32029785
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Dysregulated tgfbr2/ERK-Smad4/SOX2 Signaling Promotes lung Squamous Cell Carcinoma Formation.
    Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
    Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. GDF15 induced apoptosis and cytotoxicity in A549 cells depends on tgfbr2 expression.
    Tarfiei GA; Shadboorestan A; Montazeri H; Rahmanian N; Tavosi G; Ghahremani MH
    Cell Biochem Funct; 2019 Jul; 37(5):320-330. PubMed ID: 31172564
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.